Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
Sponsor: IHF GmbH - Institut für Herzinfarktforschung
A observational or N/A phase clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by IHF GmbH - Institut für Herzinfarktforschung and has accumulated 18 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Mar 2025 — Sep 2025 [monthly]
Completed
-
Sep 2024 — Mar 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
▶ Show 13 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Jul 2020 — Jan 2021 [monthly]
Completed
-
Jun 2020 — Jul 2020 [monthly]
Completed
-
Sep 2019 — Jun 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Jan 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- IHF GmbH - Institut für Herzinfarktforschung
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Ashkelon, Israel , Athens, Greece , Beersheba, Israel , Bergamo, Italy , Bordeaux, France , Bucheon-si, South Korea , Budapest, Hungary , Catanzaro, Italy , Daegu, South Korea and 28 more locations